Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib Vaccine Followed by the Same Vaccine and Oral Polio Vaccine

NCT01457560 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis B
Acellular Pertussis
Haemophilus Influenzae Type b
Diphtheria
Tetanus
Poliomyelitis

Interventions

BIOLOGICAL: DTPa-HBV-IPV/Hib (Infanrix hexa™)
BIOLOGICAL: OPV

Sponsor

GlaxoSmithKline